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Numerous pathogens have evolved mechanisms of co-opting normal host endocytic machinery as a means of invading host cells. While
numerous pathogens have been known to enter cells via traditional clathrin-coated pit endocytosis, a growing number of viral and bacterial
pathogens have been recognized to invade host cells via clustered lipid rafts. This review focuses on several bacterial pathogens that have evolved
several different mechanisms of co-opting clustered lipid rafts to invade host cells. Although these bacteria have diverse clinical presentations and
many differences in their pathogenesis, they each depend on the integrity of clustered lipid rafts for their intracellular survival. Bacterial invasion
via clustered lipid rafts has been recognized as an important virulence factor for a growing number of bacterial pathogens in their battle against
host defenses.
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A wide range of pathogens including parasites, viruses, and
bacteria have evolved mechanisms of invading host cells in
order to survive, and replicate [1]. Many of these organisms co-
opt host endocytic pathways in order to invade phagocytic and
non-phagocytic cells and thereby avoid host defenses [2]. The
different routes of entry used by these pathogens have a
profound effect on their pathogenesis. Even after invasion of
host cells, pathogens may still not be safe from host defenses.
Intracellular pathogens must also find a way to avoid
degradation in the acidic environment of intracellular lyso-
somes. Several pathogens have the ability to enter host cells via
the classical endosome–lysosome route involving clathrin-
coated pits but then avoid destruction within lysosomal
compartments either by preventing fusion with lysosomes or
alternatively, preventing acidification following fusion with
lysosomal compartments [2–4]. In addition to the endosome–
lysosome pathway, both phagocytic and non-phagocytic cells
have been recognized to have alternative pathways of
endocytosis [2,4]. It has recently been recognized that an
increasing number of pathogens co-opt the endocytic proper-
ties of caveolae or lipid raft to achieve entry into host cells0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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E-mail address: david.zaas@duke.edu (D.W. Zaas).[1,3,5]. Lipid rafts are plasma membrane domains that are
composed of cholesterol, glycosphingolipids, and GPI an-
chored proteins. Although initially described as plasma
membrane invaginations, caveolae are defined as caveolin-
enriched lipid rafts and are recognized to take a variety of
shapes including flat, tubular, or vesicular [6]. Caveolin
proteins are not only found in the cell membrane, but they
can also be found intracellularly as part of vesicle membranes,
the endoplasmic reticulum, or free within the cytosol [7,8].
Clustered lipid rafts are made up of an assembly of lipid raft
units which have been implicated in a variety of cellular
functions including signaling and growth regulation [9]. In
addition, clustered lipid rafts are believed constitute an
alternate pathway of endocytosis, often distinct from clathrin-
coated pits [9]. However, it has recently been recognized that
these pathways may also overlap as certain raft structures are
internalized via a clathrin-dependent mechanism [10,11]. After
endocytosis clustered lipid rafts can form intracellular vesicles
that may have a variety of fates including remaining as an
intracellular organelle or a caveosome, fusing with the
endoplasmic reticulum or Golgi network, as well as transcytos-
ing to the contralateral cell surface [12–14]. Clustered lipid
rafts are believed to play an important physiological role in
macromolecular transport [9]. The ability of pathogens to
exploit this endocytic pathway may be a key to understanding
the pathogenesis of these diverse infections. Pathogens that are1746 (2005) 305 – 313
http://www
Fig. 1. Schematic diagram showing the complex role of caveolae and lipid rafts in bacterial pathogenesis. Bacterial that co-opt this endocytic pathway are able to
survive intracellularly and avoid fusion with traditional lysosomes. These bacteria can use caveolae or lipid raft-mediated endocytosis and be targeted to a number of
different intracellular compartments. Bacterial entry through lipid rafts also allows alteration of cell signaling pathways including inflammatory cytokine production
and induction of apoptosis.
Table 1
Bacterial pathogens that co-opt lipid raft or caveolae-mediated endocytosis
Pseudomonas aeruginosa [55,66]
Escherichia. coli [38,46]
Camylobacter jejuni [71,72]
Chlamydia species [67,69]
Mycobacteria species [83–85]
Brucella species [75,77,81]
Listeria monocytogenes [88]
Shigella flexneri [16]
Ehrlichia chaffeensis [89,90]
Anaplasma phagocytophilum [89,90]
Group A Streptococci [91]
Although these bacterial pathogens have many differences in both their clinica
presentation and bacterial pathogenesis, they each have evolved mechanisms to
usurp normal host endocytic pathways as a means of invasion. The mechanism
of invasion for each of these diverse bacterial pathogens depends on the
integrity of clustered lipid rafts.
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traditional lysosomes and the contents are targeted to a range of
different intracellular compartments (Fig. 1) [6,15]. Thus, lipid
raft-mediated uptake may promote intracellular survival and
dissemination within the host.
A wide variety of bacterial pathogens have evolved
mechanisms of co-opting host endocytic pathway via clustered
lipid rafts (Table 1). While an increasing number of pathogens
are now recognized to co-opt lipid raft-mediated endocytosis as
a means of invading host cells including both viruses and
bacteria, this review will focus on a few examples where the
role of clustered lipid rafts in promoting bacterial internaliza-
tion have been better defined. The role of lipid rafts in the
adherence and uptake of bacterial toxins plays an important
role in a number of bacterial infections including shigellosis
and anthrax [10,16,17]. An outstanding review of this topic can
be in the review by Lafont and van der Goot [18]. In addition to
bacterial uptake, this review will focus on the role of some of
the key lipid raft associated proteins including caveolin
proteins that have recently been recognized to play a role in
regulating bacterial internalization. Although each of these
pathogens require clustered lipid rafts for their intracellular
survival, it is important to recognize that these structures andmechanisms are not identical. Different pathogens co-opt lipid
rafts during distinct different sections of their pathogenesis. In
addition, lipid rafts are composed of a group of heterogeneous
structures and the exact composition of these lipid rafts varies
among both cell types and pathogens. A detailed description of
the molecular biology that distinguishes these unique structuresl
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below detail the mechanism by which bacterial pathogens have
evolved the mechanism to co-opt cholesterol rich, detergent
insoluble membrane domains that as a group have been termed
clustered lipid rafts. Studying the role of lipid rafts in the
pathogenesis of these bacterial infections has allowed us great
insight into the pathogenesis of the diverse diseases as well as
better understanding into the role of lipid rafts in normal
cellular physiology.
2. Caveolin proteins
Caveolin proteins are key components of lipid rafts and
caveolae and have many important functions. Caveolin was
originally described in 1992 as Vesicular Integral Membrane
protein of 21 kDa (VIP21) [19]. VIP21 was initially identified
in epithelial cells as key molecule of vesicular transport. VIP21
was able to be identified in the Golgi apparatus, the plasma
membrane, as well as intracellular vesicles [19]. Later VIP21
was renamed caveolin-1 and continues to be recognized as an
integral protein of caveolae [20,21]. The caveolin family of
proteins is made of 3 proteins: caveolin-1, caveolin-2, and
caveolin-3. While caveolin-1 and -2 have been identified in
most cell types, the expression of caveolin-3 is restricted to
muscle [6].
While caveolae have been implicated in a number of
different cellular functions, the exact roles of caveolin-1 are
unclear. The amino and carboxy terminal of caveolin-1 resides
in the cell cytoplasm whereas the transmembrane domain of the
molecule is associated with the lower leaflet of the plasma
membrane forming a hairpin structure [19,20]. Caveolin-1
proteins interact to form homo-oligomers ranging from 300 to
400 kDa. Because of their ability to form stable homo-
oligomers, caveolin-1 has a role in determining the size and
shape of certain caveolae [22]. Oligomerization occurs in the
endoplasmic reticulum immediately after the protein in
synthesized [23]. The oligomerized form of caveolin-1 is
associated with lipid rafts in both the Golgi and the plasma
membrane. Some of these oligomers create more stable forms
which are resistant to disassociation in the presence of 2%
SDS. Electron microscopy has revealed that caveolin-1
aggregates form striated filamentous strands which coat the
cytoplasmic face of cave like plasmalemmal caveolae [23].
Caveolin-1 has also been implicated as a scaffolding protein for
organizing and concentrating caveolin-interacting signaling
molecules within caveolae [24]. Recently, studies of SV40
uptake via caveolae have identified that caveolar domains
initially form in the Golgi apparatus. In addition, there is little
exchange of caveolin-1 between difference these caveolar
domains which appear to serve a stable, fixed vesicular
transport containers [25]. These vesicles can transport cargo
to multiple different compartments and even intersect with
more traditional endocytic pathways. Stable caveolar vesicles
have been shown to transiently fuse with the early endosome
and release their contents in a pH-dependent manner [26]. It
has also been shown that phosphorylation of caveolin-1 can
trigger the flattening, aggregation, and intracellular fusion ofcaveolae and caveolae-derived vesicles [27]. In addition to
serving as key structural proteins that organize caveolae
platforms, caveolin proteins are important in regulating
endocytosis and cell signaling [28,29].
Caveolin-2 is the least well studied of the caveolin gene
family and the role of caveolin-2 in lipid raft-mediated
endocytosis is unknown. Caveolin-1 and -2 are co-expressed
on most cell types including high levels of expression on the
endothelium as well as type I pneumocytes within the alveolar
epithelium [30–32]. Caveolin-2 is the most divergent of the
caveolin gene family with only approximately 50% similarity
to caveolin-1 [33]. Caveolin-2 interacts with caveolin-1 to form
a hetero-oligomeric complex within lipid rafts [34]. Unlike
caveolin-1, caveolin-2 is not required for the formation of
caveolae and cannot form caveolae by itself [34,35]. In
addition, caveolin-2 has not been implicated as an important
regulator of endocytosis or host cell signaling pathways
[31,36]. In order for caveolin-2 to be expressed, caveolin-1 is
required as a chaperone to transport caveolin-2 to the cell
surface [37]. In the absence of caveolin-1, caveolin-2 is
degraded in the Golgi apparatus [34,37]. This dependence of
caveolin-2 on caveolin-1 expression has confounded the
studies aimed at distinguishing the function of these two key
lipid raft associated proteins. In several of the following
examples of bacterial invasion, we highlight examples where
the complex roles played by both caveolin-1 and -2 in lipid
raft-mediated endocytosis are just beginning to be understood.
2.1. Escherichia coli
E. coli was one of the first bacterial pathogens recognized to
invade host cells via clustered lipid rafts [38]. E. coli is the
most common cause of urinary tract infections as well as a
frequent cause of extraintestinal infections [39]. Like many
other gram-negative bacteria, E. coli possess fimbriae or pili.
The major virulence factors expressed by uropathogenic E. coli
is the FimH adhesin, a mannose-binding lectin on the tips of
bacterial fimbrial appendages. FimH allows the bacteria to bind
to cells and colonize mucosal surfaces [40,41]. E. coli was
traditionally considered an extracellular pathogen, but has
increasingly been recognized to invade multiple cell types. It
was initially discovered that FimH expressing E. coli were
internalized by macrophages and mast cells [38,42]. These
bacteria were able to survive and replicate within intracellular
vesicles and avoid fusion with lysosomes. In contrast, E. coli
that were opsonized with antibodies were internalized by a
different mechanism, trafficked to acidic lysosomes, and
rapidly degraded. Opsonization has been shown for other
pathogens to have similar effects in determining the mechanism
of uptake. The unopsonized pathogens enter via clustered lipid
rafts and are able to survive intracellularly, whereas the
opsonized pathogens are uptaken via traditional clathrin-coated
pits and degraded with intracellular lysosomes [43]. Subse-
quently, the receptor for FimH expressing E. coli was identified
as a glycosylphophatidylinositol (GPI) anchored protein, CD48
[38]. Since GPI linked proteins are predominantly located
within lipid rafts, this discovery gave the first hint of the
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lipid rafts by using cholesterol depleting agents such as methyl-
h-cyclodextrin, filipin or nystatin markedly decreased the entry
of FimH expressing E. coli. On the other hand, cholesterol
disrupting agents had no effect on the uptake of antibody-
coated E. coli [38]. Thus, a traditionally extracellular pathogen,
E. coli, is able to invade macrophages and mast cells by co-
opting the host pathway of lipid raft-dependent endocytosis.
These series of observations were the first description of this
novel bacterial pathway for invasion via clustered lipid rafts.
Mucosal surfaces of the respiratory, gastrointestinal and
genitourinary tracts represent the major sites of initiating
microbial infections; therefore, it was important to determine
if E. coli can invade epithelial cells via similar mechanisms.
The mucosal epithelium performs an important barrier function
and is not typically amenable to bacterial invasion. The bladder
epithelium is also especially highly impermeable to invasion
because of the role of the bladder as a storage organ for urine.
The presence of ‘‘plaques’’ comprising of uroplakin proteins
localized on the luminal surface of superficial bladder and their
association with clusters of cholesterol and sphingolipids is
believed to contribute to a more ordered lipid structure in the
plasma membrane, lowering membrane fluidity and perme-
ability. The virulence of E. coli in the bladder has also been
linked to the expression of FimH. While FimH binds CD48 on
mast cells and macrophages, FimH binds to uroplackin-1a on
the plasma membranes of bladder cells. FimH binding to
uroplackin promotes not only bacterial attachment but also
bacterial invasion of these relatively impermeable cells [44,45].
The involvement of clustered lipid rafts in the invasion of the
bladder epithelium by E. coli was deduced from the observa-
tion that the FimH receptor, uroplackin 1a, was specifically
localized to lipid raft fractions of bladder cell extract [46].
Disruption of lipid rafts with cholesterol depleting agents has
been shown to inhibit E. coli invasion of bladder epithelial
cells both in vitro and in vivo. In addition, by using confocal
microscopy it has been shown that intracellular E. coli are
surrounded by vesicles enriched in lipid raft components
including GM1, cholesterol and caveolin-1 [46].
Caveolin-1 has been implicated as a key structural
component of caveolae that interacts with both the cytoskeleton
[47] as well as key signaling molecules [48,49] and may be a
critical regulator of bacterial uptake via clustered lipid rafts.
Caveolin-1 appears to be critically important for E. coli entry
into bladder epithelial cells. Decreased expression of caveolin-
1 by using RNA interference markedly decreased the ability of
E. coli to invade bladder epithelial cells [46]. In contrast,
caveolin-1 expression appears to downregulate uptake of
proteins such as Autocrine Motility Factor (AMF-1) [50]. It
has been proposed that caveolin-1 expression may decrease
membrane fluidity and therefore decreased caveolin-1 expres-
sion can lead to increased caveolae-mediated uptake of specific
proteins. In contrast, uptake of large bacterial pathogens such
as E. coli via clustered lipid rafts is dependent on caveolin-1
expression. It is possible that caveolin-1 is required for
formation of the large platforms that control lipid raft-
dependent bacterial uptake or alternatively caveolin-1 expres-sion could exert its effect via changes in cell signaling
cascades. No longer considered predominantly an extracellular
pathogen, an important virulence factor of E. coli is the ability
to invade host cells via clustered lipid rafts and is dependent on
membrane cholesterol as well as caveolin-1 expression.
2.2. Pseudomonas aeruginosa
Pseudomonas aeruginosa is an important cause of nosoco-
mial pneumonia, as well as a major pulmonary pathogen in
patients with cystic fibrosis and other immunocompromising
conditions [51–54]. Pseudomonas was initially shown to
invade both nasal and bronchial epithelial cells via ceramide
rich lipid rafts [55]. It has been proposed that Pseudomonas
stimulates lipid raft associated receptors and induces transfor-
mation of small lipid rafts into large insoluble membrane
platforms [55]. For example, stimulation of CD95 and CD40
induces this membrane reorganization by exposing the enzyme
acid sphingomyelinase on the extracellular leaflet of the plasma
membrane and converting sphingomyelin to ceramide [56].
Pseudomonas infection of airway epithelial cells has been
shown to induce the formation of these large ceramide rich
lipid rafts which play a critical role in mediating bacterial
invasion [55]. Removal of membrane cholesterol with methyl-
h-cyclodextrin inhibits both ceramide rich raft formation and
Pseudomonas invasion of nasal and airway epithelial cells both
in vitro and in vivo [55,57].
Ceramide rich lipid rafts have been implicated to serve
many roles in the pathogenesis of Pseudomonas infections
including the regulation of apoptosis and cytokine production.
Ceramide rich lipid rafts are important in clustering cell surface
receptors and cell signaling proteins [56]. Pseudomonas
upregulates CD95 expression within lipid rafts via its type III
secretion system. Pseudomonas infection leads to ligation of
the CD95 receptor and induces epithelial cell apoptosis.
Disruption of lipid rafts with methyl-h-cyclodextrin inhibits
the CD95-dependent apoptosis. In addition, mice lacking
CD95 have an increased susceptibility to Pseudomonas
infections [55]. Therefore, it appears that both Pseudomonas
invasion and CD95-dependent apoptosis of bronchial epithelial
cells is dependent on the integrity of lipid rafts and a crucial
host defense mechanism to Pseudomonas infection.
Pseudomonas infection of upper airway epithelial cells
leads to the production of inflammatory cytokines including
IL-1h. Lipid rafts are believed to play an important role in
regulating cytokine production due to their ability to organize
cell surface receptors and cell signaling molecules in special-
ized domains. One model has proposed that the chloride
channel CFTR, which is defective in Cystic Fibrosis, may serve
as a cell surface receptor for Pseudomonas [57]. CFTR clusters
into lipid rafts only after Pseudomonas infection and co-
localizes with the lipid raft marker GM1 and Pseudomonas.
Disruption of lipid rafts with methyl-h-cyclodextrin inhibits
migration of wild type CFTR proteins and mutant forms of the
CFTR protein are unable to localize to the lipid raft domains on
the plasma membrane. Pseudomonas infection via CFTR
induces NF-KB activation and the induction of cytokine
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activation of NK-KB that is believed to play a role in the host
defense against Pseudomonas [57]. In contrast, disruption of
lipid rafts prior to Pseudomonas infection of epithelial cells
leads to markedly increased levels of IL-1B and a greater
inflammatory response [55]. Lipid rafts appear to be important
regulators of cytokine production in response to Pseudomonas
possibly via uptake of bacteria which may interfere with gene
transcription or protein translation. Alternatively, the organi-
zation of lipid rafts may be required for alignment of key
regulatory molecules. Instead of protecting the host by
enhancing bacterial clearance, this exaggerated inflammatory
response after disruption of lipid rafts directly leads to
increased morbidity and mortality from uncontrolled inflam-
mation [55]. While invasion via lipid rafts appears to offer an
advantage to the bacteria by avoiding host defenses, it is
possible that lipid raft-mediated invasion of Pseudomonas in
the upper airways may actually be protective to the hosts. Lipid
rafts play a key role in cell signaling events such as regulation
of apoptosis and cytokine production after Pseudomonas
infection of airway epithelial cells. Lipid rafts are important
for the regulation of NF-KB and the production of inflamma-
tory cytokines after Pseudomonas infection. However, it also
appears that lipid rafts may play a key role as a downregulator
of certain chemokines including IL-1B in order to limit the
inflammatory response.
The complex role of lipid rafts in the pathogenesis of
Pseudomonas infections is just beginning to be understood but
the mechanism of these diverse responses may be due to the
sequestration of signaling molecules within rafts that determine
their function. Another example of lipid raft-mediated regula-
tion of cell signaling cascades and cytokine production has
been revealed in studies of CD45 on T cells. CD45 is a cell
surface molecule that is recruited to lipid rafts after T cell
activation. Once localized to lipid rafts CD45 inhibits IL-2
production, whereas raft excluded CD45 is able to induce IL-2
production [58]. This compartmentalization of signaling
receptors is increasing being recognized as a mechanism to
regulate various signal transduction pathways. It was initially
recognized that signal transduction pathways could be turned
off by internalization of cell surface receptors and degradation
within lysosomes [59,60]. More recently, it has been recog-
nized that cell surface receptors can move in and out of lipid
raft domains as a dynamic means of regulating their activity
[61]. The pathogenesis of Pseudomonas shows that bacteria
appear to have evolved means of altering these lipid raft-
dependent cell signaling pathways to not only to increase
bacterial internalization but also to modify the host inflamma-
tory response. Alterations in host cell signaling pathways likely
play a critical role in the pathogenesis of Pseudomonas as well
as numerous other bacterial pathogens.
A large number of patients develop Pseudomonas coloniza-
tion of the upper airways; however, only a small percentage of
these patients develop clinically significant Pseudomonas
pneumonia. The establishment of pneumonia is usually depen-
dent on dissemination of Pseudomonas respiratory infections to
the alveolar space [52,62,63]. The alveolar epithelium is thelargest host epithelial surface exposed to the external environ-
ment with an area roughly equal to the size of a tennis court.
Approximately 95% of that surface area is lined by specialized
type I pneumocytes [52]. Type I pneumocytes are elongated,
epithelial cells that perform gas exchange within the lung and are
also constantly exposed to the external environment and
bacterial pathogens. The cell membrane of type I pneumocytes
has a high concentration of specialized lipid rafts and caveolae
which occupy nearly 70% of the plasma membrane [64,65].
Invasion of type 1 pneumocytes would protect Pseudomonas
from phagocytosis by alveolar macrophages and offer a
protected environment for replication. Pseudomonas invasion
of type I cells may facilitate dissemination throughout the host
due to the single cell thickness of the alveolar epithelium.
Pseudomonas invades type I pneumocytes during the patho-
genesis of pneumonia both in vitro and in vivo. Pseudomonas
invasion of type I-like cells is specifically inhibited by low doses
of nystatin, filipin, and methyl-h-cyclodextrin. Intracellular
Pseudomonas within alveolar epithelial cells is located within
vacuolar membranes that are enriched in lipid raft components
including caveolin-1 and -2 [66].
Pseudomonas invasion of alveolar epithelial cells was
significantly decreased after RNAi downregulation of both
caveolin-1 and caveolin-2 expression [66]. Since caveolin-1 is
required for caveolin-2 expression, caveolin-1-deficient cells
are also deficient in caveolin-2 [37,66]. Therefore, it has been
speculated that caveolin-2 may play a novel, critical role in
regulating caveolae medicated endocytosis. The mechanism by
which caveolin-2 may influence the endocytic pathway is just
beginning to be understood. Changes in caveolin protein
expression may alter the membrane fluidity or alternatively
caveolin expression may change host cell signaling pathways
in order to influence endocytosis. Pseudomonas invasion is
inhibited by the tyrosine kinase inhibitor, genistein, and
increased after treatment with the phosphatase inhibitor,
okadaic acid [66]. Pseudomonas infection of alveolar epithelial
cells leads to increased tyrosine phosphorylation of caveolin-2.
In addition, the changes in invasion after treatment with these
drugs correlate with the changes in tyrosine phosphorylation of
caveolin-2 [66]. Pseudomonas has the ability to invade both
airway and alveolar epithelial cells via caveolin-enriched lipid
raft and manipulate host cell signaling pathways. Thus,
clustered lipid rafts appear to play a complex role in this
evolutionary battle between the pathogen and the host defenses
within the lung.
2.3. Chlamydia trachomatis
Chlamydia is an obligate intracellular bacterial pathogen
that is believed to exploit lipid rafts in order to invade both
phagocytic and non-phagocytic cells [67]. Chlamydia species
are a common bacterial cause of sexually transmitted diseases
as well as pneumonia. Similar to E. coli and Pseudomonas,
disruption of lipid rafts with methyl-h-cyclodextrin, nystatin,
or filipin inhibits invasion of Chlamydia species utilizing lipid
rafts for entry [67]. The invasion of C. trachomatis, pneumo-
niae and C. psittaci have been shown to be inhibited by
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rafts as mechanisms of invasion [67]. However, not all species
of Chlamydia are identical. Although C. trachomatis serovar D
invasion in dependent on membrane cholesterol, serovars A
and C are not inhibited by disruption of lipid rafts. Alterna-
tively, these serovars are believed to enter cells via clathrin-
coated pit-mediated endocytosis [67]. Finally, the mechanism
of invasion used by serovars E and K is still controversial as
opposite conclusions have been reached by separate investiga-
tors [67,68]. The different routes of entry are possibly due to
the different cell surface molecules that serve as receptors for
different serovars and whether or not they are located within
lipid rafts on the plasma membrane of host cells. In addition,
the route of invasion may differ based on the cell type or
growth phase of the bacterial pathogen. Further evidence of the
role of clustered lipid rafts in the pathogenesis of Chlamydia
infections has been provided by confocal microscopy analysis
of infected cells in vitro. Intracellular Chlamydia including C.
pneumoniae and trachomatis co-localize with caveolin pro-
teins. While caveolin-1 and -2 are both co-localized with C.
pneumoniae and C. trachomatis serovars E. F, and K, only
caveolin-2 was associated with C. trachomatis serovars A, B,
C. In addition, caveolin-2 specifically accumulates with the
bacterial pathogen at the inclusion membrane [69,70]. The
microscopy studies provide further evidence that different C.
trachomatis serovars have distinct mechanisms of invasion.
Caveolin-1 does not appear to be required for Chlamydia
uptake since invasion of FRT cells that lack caveolin-1
expression was not different than caveolin-1 expressing cells.
Regardless of the expression of caveolin-1, the invasion of
these strains is inhibited by disruption of lipid rafts [67]. These
studies provide further evidence for the importance of caveolin-
2, independent of caveolin-1 in the uptake of bacterial
pathogens. Unlike E. coli and Pseudomonas, strains of
Chlamydia are capable of actively modifying the composition
of their intracellular compartments to promote intracellular
growth [67]. Although each of these pathogens has evolved
unique mechanisms of survival within host cells, their
pathogenesis all require the integrity of clustered lipid rafts to
survive.
2.4. Campylobacter jejuni
Campylobacter jejuni, one of the leading causes of
diarrhea, is required to invade intestinal epithelial cells in
order to cause clinical symptoms. It has long been recognized
that campylobacter can invade intestinal epithelial cells and is
viable within intracellular vacuoles [71]. While the receptor on
epithelial cells for Campylobacter has not been clearly
identified, lipid rafts are required for the entry of C. jejuni
into the enterocyte-like cell line, Caco-2 [72]. Pre-treatment
with filipin or cholera toxin significantly decreased the
number of intracellular bacteria after campylobacter infection
in vitro [72]. In addition, Campylobacter interaction with lipid
rafts also affects host cell signaling pathways. Staurosporine, a
non-specific kinase inhibitor, caused a dramatic reduction in
the number of intracellular bacteria. Pre-treatment with thetyrosine kinase inhibitor, genistein, inhibited Campylobacter
uptake but had no effect on the uptake of salmonella which
utilizes a mechanism often defined as macro-pinocytosis to
achieve entry into host cells. Finally, Campylobacter uptake
was inhibited by wortmannin, a PI-3 kinase inhibitor [72].
Although not yet completely understood, these observations
imply that Campylobacter are capable of co-opting clustered
lipid rafts in order to achieve entry into host cells and the
mechanism involves tyrosine phosphorylation of certain host
cell substrates.
2.5. Brucella abortus
Brucella are gram-negative facultative intracellular bacteria
which cause Brucellosis or Mediterranean Fever which is the
most frequent human zoonosis, most prevalent in the Middle
East and India [73]. Clinical manifestations of Brucellosis
include fever, arthritis, endocarditis, and meningitis. A key
event in the pathogenesis of Brucellosis is infection of
macrophages and survival within membrane bound intracellu-
lar organnelles. Brucella is an intracellular pathogen and one of
the main virulence factors is its ability to invade macrophages
via lipid rafts and replicate intracellularly. Brucella invades
macrophages via a membrane ruffling and macropinosomes
which selectively express lipid raft associated markers includ-
ing GM1 and cholesterol [74]. After internalization, Brucella
then inhibits phagosome–lysosome fusion and transits through
a novel intracellular compartment [75]. Disruption of lipid rafts
with methyl-h-cyclodextrin or filipin inhibits the lipid raft-
mediated entry and survival of Brucella [75]. In addition,
different species of Brucella have different means of invading
host macrophages [76,77]. Brucella species express both rough
and smooth variants of lipopolysaccharide (LPS) and the
expression of the O side chain is recognized as a major
virulence factor and an important determinant of bacterial
entry. Smooth variants of LPS express the O side chain and
avoid lysosomal fusion; however, rough mutants fail to express
the O side chain and do not enter via lipid rafts [78,79].
Brucella is also known to contain a type IV secretion system
which is important for bacterial invasion [80]. Recent work has
shown that establishment of an intracellular Brucella infection
is regulated by the activities of the type IV secretion system.
Heat shock protein 60 (Hsp60) is secreted by Brucella and
binds to the cellular prion protein prior to invasion. The cellular
prion protein is incorporated into intracellular organelles that
contain Brucella and deficiencies in the cellular prion protein
prevented internalization and intracellular survival [77,81].
Brucella provides another unique and fascinating example how
pathogens have learned to use host lipid rafts in order to gain a
survival advantage and cause clinical manifestations of disease.
2.6. Mycobacteria
Mycobacteria are another intracellular pathogen that invade
and survive within macrophages. Mycobacteria are successful
in avoiding host defenses by resisting delivery to lysosomes
and replicating within the mycobacterial phagosome following
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the active recruitment of a tryptophane-aspartate containing
coat protein (TACO/Coronin 1) into the host cell membrane
encasing the bacteria [83,84]. TACO/Coronin 1 prevents fusion
of the mycobacterial phagosome with the lysosome. Choles-
terol is required for both the uptake of mycobacteria and for the
association of TACO/Coronin 1 with the phagosomal mem-
brane [83,84]. When murine macrophages were infected with
M. bovis, cholesterol accumulates at the site of bacterial entry
and around intracellular mycobacteria. Depletion of membrane
cholesterol with lovastatin and methyl-h-cyclodextrin reduced
M. bovis andM. tuberculosis uptake by nearly 90% [84]. These
agents contributed to the solubilization of TACO/Coronin 1
and disengagement from the phagosomal membrane In the case
of Mycobacterium avium, disruptors of lipid rafts inhibit
bacterial infection of J774 murine cells by blocking the
recruitment and formation of lipid rafts in areas of the plasma
membrane in direct contact with bacteria [85]. Complement
receptor 3 (CR3) is one of the receptors for mycobacteria that
has been implicated in the lipid raft-dependent uptake [86].
CR3 is associated with GPI anchored proteins and is
preferentially localized to lipid rafts. Antibodies against CR3
inhibit uptake of mycobacteria, L. casei, and zymosan.
However, disruption of cholesterol only inhibited mycobacte-
rial uptake and had no effect on the uptake of L. casei and
zymosan [86]. Disruption of cholesterol redistributes CR3 to
non-lipid raft regions of the plasma membrane [86]. Therefore,
disruption of cholesterol does not inhibit CR3 function, but
rather inhibits the complex interaction with CR3, GPI anchored
proteins and cholesterol which is essential for the endocytic
process. A number of mycobacterial species have been added
to the growing list of pathogens who have been recognized to
utilize lipid raft domains for invasion the invasion and survival
within host cells.
3. Conclusion
Caveolae and lipid rafts play a number of important roles in
normal cellular functions including cholesterol metabolism,
cell signaling, and endocytosis [6,61]. Over the last several
years, these microdomains have been recognized to play a role
in the uptake of many intracellular pathogens including viruses,
parasites, and bacteria [1]. The list of bacteria that depend on
these cholesterol enriched domains for intracellular survival
includes E. coli [38,46], P. aeruginosa [55,66], Chlamydia
[67], Brucella [74,76], and mycobacteria [84,86]. Despite the
many differences in the pathogenesis of these different
infections, they all appear to utilize clustered lipid rafts in
order to achieve entry and survival within host cells [5,15].
Each of these bacterial pathogens has significantly different
mechanisms of pathogenesis and diverse clinical presentations,
yet they share a very basic common mechanism of invasion.
The evolutionary advantage provided by co-opting lipid raft-
mediated endocytosis played an important role development of
each of these unique pathogens. Bacteria have evolved
mechanisms of co-opting clustered lipid rafts to invade a wide
range of phagocytic and non-phagocytic cells. Once intracel-lular, these pathogens are able to avoid acidic lysosomes and
intracellular degradation [3]. Caveolin-1 and -2 are two
examples of key lipid raft associated proteins that have recently
been implicated to play a key role in regulating this novel
pathway of pathogen invasion [46,66]. The recent description
of the caveolin-1- and -2-deficient mice [30,31] will hopefully
allow an in vivo examination of the roles these proteins may
play in the pathogenesis of a wide range of bacterial infections.
This mechanism of invasion may allow replication within the
protected intracellular environment and facilitate dissemination
within the host. On the other hand, some investigators have
implicated lipid raft-dependent endocytosis as a key compo-
nent of the host defense against bacterial infection. The ability
to internalize pathogens via clustered lipid rafts may signal
apoptosis and allow the host to eliminate infected cells [55]. In
addition to co-opting lipid raft-mediated endocytosis, patho-
gens can alter lipid raft associated signaling cascades. Lipid
rafts cluster key signaling molecules and have been shown to
regulate key components of the host defense against infections
including inflammatory cytokine production [55,87]. The
complex role lipid rafts play in these different aspects of
bacterial pathogenesis is just beginning to be understood (Fig.
1). The list of pathogens that depend on clustered lipid rafts for
invasion and intracellular survival will likely continue to grow.
By studying the role of lipid rafts in bacterial pathogenesis, we
may be able to get a better understanding of the disease
mechanisms and hopefully design more effective treatment
strategies. In addition, these pathogens allow us to better
understand the natural conserved role that lipid raft-mediated
endocytosis plays in cellular homeostasis.References
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